Login / Signup

Incidence and Predictors of Relapse After Stopping Antiviral Therapy in Pediatric Chronic Hepatitis B.

Piyush UpadhyayBikrant Bihari LalVikrant SoodRajeev KhannaEkta GuptaArchana RastogiSeema Alam
Published in: The Pediatric infectious disease journal (2022)
Discontinuation of antiviral treatment in children with CHB resulted in relapse in one-third of the patients. Relapse was frequent in those who were HBeAg-positive at the time of stopping therapy and in those who required longer therapy for HBV-DNA to become undetectable.
Keyphrases
  • hepatitis b virus
  • end stage renal disease
  • free survival
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • young adults
  • single molecule
  • stem cells
  • mesenchymal stem cells
  • replacement therapy
  • liver fibrosis